Anthem Biosciences IPO: The Bengaluru-based company, Anthem Biosciences, has secured Rs 1,016 crore from anchor investors ...

Chinese traders are pulling back from the dollar, helping ease a shortage that has rattled the banking system and setting the ...

Equity-only put-call ratios have continued to fall. That is bullish for stocks, and as long as these ratios are declining, stocks can advance. The fact that they are making new relative lows on their ...

Charleston International Airport breaks ground on a $100 million expansion project. Quarterly earnings seasons ramps up again with several major financial firms reporting their latest earnings, ...

Global banks channeled more than $385 billion to the coal power industry over the past three years, with annual flows ...

US markets are nearing record highs ahead of a weak second-quarter earnings season, with analysts forecasting just 2.5% ...

Some NDAs bar victims from speaking to anyone, even doctors, about their experience. Read more at straitstimes.com. Read more ...

Former Republican New York Rep. George Santos said he fears for his life in prison during a Friday interview with ...

Despite recent global market uncertainties, several IPOs are launching. Upcoming listings include Travel Food Services and ...

US stocks have swung from a dramatic April selloff to new heights. Now, traders are about to see if Corporate America’s report cards justify the optimism priced into equity markets.

Anthem Biosciences has raised Rs 1,016 crore from anchor investors ahead of its initial share-sale opening for public subscription.